Wednesday, February 10, 2010, 8:49am EST - Canadian Markets open in 41 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

(CGRB)

 On Dec 31: 0.00 USD   0.00 (0.00%)  
MORE ON CGRB
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
(NGM:CGRB) Delayed quote dataEdit
Last Trade: 0.00 USD
Trade Time: Dec 31
Change: 0.00 (0.00%)
Prev Close: N/A
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: 39.00
Day's Range: N/A - N/A
52wk Range: 16.35 - 45.00
Volume: 0
Avg Vol (3m): 435,814
Market Cap: N/A
P/E (ttm): N/A
EPS (ttm): N/A
Div & Yield: N/A (N/A%)
(CGRB)
1d  5d  3m  6m  1y  2y  5y 
 Add CGRB to Portfolio   Download Data

HEADLINES
• [$$] JNJ Preview: Medical Devices Should Be the Highlight
at RealMoney by TheStreet.com (Mon, Oct 12)
• COUGAR BIOTECHNOLOGY, INC. Files SEC form 8-K, Changes in Control or Registrant, Change in Directors or Principal Off
EDGAR Online (Thu, Jul 9)
• [video] China Watch: Yongye Biotechnology
at TheStreet.com (Wed, Jun 17)
• COUGAR BIOTECHNOLOGY, INC. Files SEC form 8-K, Other Events
EDGAR Online (Mon, Jun 1)
• OncoGenex Prostate Drug Extends Survival in Study
at TheStreet.com (Sat, May 30)
• Study: OncoGenex Prostate Drug Extends Survival
at TheStreet.com (Sat, May 30)
• OncoGenex Prostate Drug Extends Survival
at TheStreet.com (Sat, May 30)
• This Company Is Hot and Going Places
at Motley Fool (Fri, May 29)
• Pharma's Feeding Frenzy
at CNBC (Thu, May 28)
• COUGAR BIOTECHNOLOGY, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and E
EDGAR Online (Wed, May 27)
More Headlines for CGRB...
ANALYST
EPS Est (next year) (Dec-09) : N/A
EPS Est (in 2 years) (Dec-10) : N/A
Avg Rec (current)*: 3.0
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
No business summary available for CGRB.


Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices